Jonathan Weinberg - 01 Mar 2023 Form 4 Insider Report for Evolent Health, Inc. (EVH)

Role
General Counsel
Signature
/s/ Jonathan Weinberg
Issuer symbol
EVH
Transactions as of
01 Mar 2023
Transactions value $
-$196,913
Form type
4
Filing time
03 Mar 2023, 16:35:29 UTC
Previous filing
23 Feb 2023
Next filing
26 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EVH Class A Common Stock Award $0 +12.8K +8.93% $0.00 156K 01 Mar 2023 Direct F1, F2, F3
transaction EVH Class A Common Stock Tax liability -$79.9K -2.27K -1.46% $35.26 153K 01 Mar 2023 Direct F3, F4
transaction EVH Class A Common Stock Tax liability -$117K -3.33K -2.17% $35.15 150K 02 Mar 2023 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units granted to Mr. Weinberg pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.
F2 Securities vest at a rate of 34% on March 1, 2024, and 33% on March 1, 2025, and March 1, 2026.
F3 Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
F4 This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units.